Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 20, 2004
Potent non-peptide thrombin receptor antagonistsSamuel Chackalamannil, Ho-Sam Ahn, Yan Xia, et al.Current Pharmaceutical Design|October 8, 2003
Development of proteinase-activated receptor 1 antagonists as therapeutic agents for thrombosis, restenosis and inflammatory diseasesHo-Sam Ahn, Samuel Chackalamannil, George Boykow, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Himbacine-derived thrombin receptor antagonists: c7-aminomethyl and c9a-hydroxy analogues of vorapaxarMariappan V Chelliah, Samuel Chackalamannil, Yan Xia, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Himbacine-derived thrombin receptor antagonists: c7-spirocyclic analogues of vorapaxarMariappan V Chelliah, Keith Eagen, Zhuyan Guo, et al.Bioorganic & Medicinal Chemistry Letters|October 5, 2010
Discovery of a vorapaxar analog with increased aqueous solubilityYan Xia, Samuel Chackalamannil, William J Greenlee, et al.Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Himbacine derived thrombin receptor (PAR-1) antagonists: structure-activity relationship of the lactone ringYan Xia, Samuel Chackalamannil, Tze-Ming Chan, et al.Journal of Medicinal Chemistry|May 2, 2008
Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activitySamuel Chackalamannil, Yuguang Wang, William J Greenlee, et al.Bioorganic & Medicinal Chemistry Letters|March 13, 2012
Discovery of nor-seco himbacine analogs as thrombin receptor antagonistsMariappan V Chelliah, Samuel Chackalamannil, Yan Xia, et al.Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ringYan Xia, Samuel Chackalamannil, Martin Clasby, et al.Journal of Medicinal Chemistry|September 16, 2005
Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agentsSamuel Chackalamannil, Yan Xia, William J Greenlee, et al.Pageof 2